drugset / Trial / NCT04741789

Managed Access Programs for INC280, Capmatinib

NCT04741789 ↗

Expanded access No longer available Novartis Pharmaceuticals

Summary

The purpose of this registration is to list Managed Access Programs (MAPs) related to INC280, Capmatinib

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Background Capmatinib Small molecule — Oral